As fiscal pressures deepen from aging populations and pandemic-era debt, governments are increasingly tapping into a tempting source of capital: citizens’ retirement savings. Pension fund assets across the Organization for Economic Cooperation and Development have more than tripled since 2003, reaching $63.1 trillion in 2024, according to the Mercer CFA Institute Global Pension Index. That enormous growth has drawn fresh political attention at a time when most countries are battling debt overhangs, making that capital look irresistible. However, the trouble starts when governments interfere and tell funds to invest too much at home, which breaks the delicate balance that fund…
Author: usaeverydaylife
Automaker Stellantis is making $13 billion bet on a U.S. comeback, after a rough 2024 and a $2.7 billion net loss in the first half of 2025.High prices and stale products scuttled what had been a highly successful first few years of the combined company. Stellantis was the product of a merger of French company Peugeot and Italian American company Fiat-Chrysler. Joining forces allowed the automakers to save more than $8 billion through sharing parts and streamlining operations, roughly double what the deal had promised investors.Pandemic-era shortages also allowed Stellantis raise prices on the vehicles it could sell when inventories…
CNBC’s Kate Rogers joins ‘Fast Money’ with an update in Starbucks’ Chinese oper Source link
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California, U.S., Sept. 30, 2025. Mike Blake | ReutersPfizer on Monday said it filed a second lawsuit against Novo Nordisk and Metsera, alleging that the Danish drugmaker’s attempt to outbid Pfizer to acquire the obesity biotech is anticompetitive. Pfizer alleges that Ozempic maker Novo Nordisk’s proposed acquisition of Metsera would help it maintain its dominant position in the blockbuster obesity market by eliminating a smaller potential competitor, according to the lawsuit filed Monday in the U.S. District Court in Delaware. The suit also alleges…
Alex Karp, Palantir CEO, joins CNBC’s ‘Squawk on the Street’ on June 5, 2025. CNBCPalantir CEO Alex Karp took on a familiar target during the company’s earnings call on Monday: His critics.”Please turn on the conventional television and see how unhappy those that didn’t invest in us are,” Karp said, after the data analytics company reported better-than-expected third-quarter results. “Enjoy, get some popcorn, they’re crying. We are every day making this company better and we’re doing it for this nation, for allied countries.”Palantir shares are up 25-fold in the past three years, lifting its market cap to over $490 billion…
Evercore ISI’s Julian Emanuel joins ‘Fast Money’ to talk the results of its recent investors survey. Source link
Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last look at today. Sign up for free to receive it directly in your inbox. Here’s what CNBC TV’s producers were watching on Monday and what’s on the radar for Tuesday’s session. Pfizer reports in the morning The pharmaceutical giant releases quarterly numbers Tuesday morning live on “Squawk Box” with Becky Quick, Andrew Ross Sorkin and Joe Kernen. The team will have the numbers and stock reaction. Shares of Pfizer are up 5% in the three months since the company’s last earnings…
CFOTO | Future Publishing | Getty Images The “everything store” might have secured its biggest customer yet.On Monday, Amazon announced that it had signed a $38 billion deal with OpenAI, offering the ChatGPT maker access to Amazon Web Services’ infrastructure.On the one hand, the move isn’t too surprising — a continuation of OpenAI’s spending spree as it looks to secure resources to run its power-hungry artificial intelligence models.On the other, OpenAI’s turn to Amazon shows that the firm is diversifying from its reliance on Microsoft, which had been its exclusive cloud services provider until this year. That could suggest OpenAI is getting…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailFast MoneyWill Lewis, Insmed CEO, joins ‘Fast Money’ to talk Insmed’s rare gene therapy development, demand, and quarterly results.05:013 hours ago Source link
CNBC’s Jim Cramer on Monday rejected concerns of market cap concentration in the Magnificent Seven, saying they are tied together because of their high growth rates rather than their products.”It’s growth that matters to stock investors, not the data center, not accelerated computing, not even artificial intelligence,” he said. “Growth is what the Magnificent Seven have in common and growth is what the market always loves.”The Magnificent Seven — Amazon, Alphabet, Meta, Apple, Microsoft, Nvidia and Tesla — are some of the biggest names on the market, with artificial intelligence chip giant Nvidia recently becoming the first company to hit…
